Additional information
| Use in sports | None |
|---|---|
| Substance class | Alkylating agent |
| Side effects | Myelosuppression, nausea, vomiting, diarrhea, fatigue, fever, anemia |
| Effects | Induces breaks in DNA strands, leading to cell death |
| Dosage (sports) | Not applicable |
| Dosage (medical) | Typically 100 mg/mВІ on days 1 and 2 of a 28-day cycle, intravenously |
| Half-life | Approximately 40 minutes |
| Main action | Antineoplastic |
| Formula | C16H21Cl2N3O2 |
| Water Retention | Not typically associated |
| Chemical name | 4-{5-[Bis(2-chloroethyl)amino]-1-methyl-1H-benzimidazol-2-yl}butanoic acid |
| Storage conditions | Store at 25В°C (77В°F), excursions permitted to 15-30В°C (59-86В°F) |
| Trade name | Treanda, Bendeka |
| Blood pressure | Potential for hypertension |
| Also known as | SDX-105 |
| Lab Test | Monitoring of blood counts and renal function |
| Hepatotoxicity | Mild to moderate potential |
| Manufacturer | Pharmaceutical |
Reviews
There are no reviews yet.